149 related articles for article (PubMed ID: 37712767)
1. A Review of Helicobacter pylori Diagnostics in Africa : From the Bedside to the Laboratory.
Archampong T; Tachi K; Duah A
J Clin Gastroenterol; 2023 Nov-Dec 01; 57(10):977-982. PubMed ID: 37712767
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Helicobacter pylori and peptic ulcer in India.
Singh V; Trikha B; Nain CK; Singh K; Vaiphei K
J Gastroenterol Hepatol; 2002 Jun; 17(6):659-65. PubMed ID: 12100610
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary.
McMahon BJ; Bruce MG; Koch A; Goodman KJ; Tsukanov V; Mulvad G; Borresen ML; Sacco F; Barrett D; Westby S; Parkinson AJ
Epidemiol Infect; 2016 Jan; 144(2):225-33. PubMed ID: 26094936
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative.
Beresniak A; Malfertheiner P; Franceschi F; Liebaert F; Salhi H; Gisbert JP
Helicobacter; 2020 Aug; 25(4):e12693. PubMed ID: 32285569
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
Sonnenberg A
Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
[TBL] [Abstract][Full Text] [Related]
7. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
Fendrick AM; Chernew ME; Hirth RA; Bloom BS
Yale J Biol Med; 1996; 69(2):187-95. PubMed ID: 9112750
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
[TBL] [Abstract][Full Text] [Related]
9. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection.
Lam SK; Talley NJ
J Gastroenterol Hepatol; 1998 Jan; 13(1):1-12. PubMed ID: 9737564
[TBL] [Abstract][Full Text] [Related]
10. Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic Sardinian patients.
Dore MP; Marras G; Rocchi C; Soro S; Loria MF; Bassotti G; Graham DY; Malaty HM; Pes GM
Intern Emerg Med; 2015 Oct; 10(7):787-94. PubMed ID: 25739590
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?
Jyotheeswaran S; Shah AN; Jin HO; Potter GD; Ona FV; Chey WY
Am J Gastroenterol; 1998 Apr; 93(4):574-8. PubMed ID: 9576450
[TBL] [Abstract][Full Text] [Related]
12. Dyspepsia, peptic ulcer, and H. pylori: a remembrance of things past.
Vakil N
Am J Gastroenterol; 2010 Mar; 105(3):572-4. PubMed ID: 20203639
[TBL] [Abstract][Full Text] [Related]
13. Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Hansen JM; Wildner-Christensen M; Hallas J; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2008 May; 103(5):1106-13. PubMed ID: 18445098
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of Helicobacter pylori infections--how, when and in whom?].
Wildner-Christensen M; Schaffalitzky de Muckadell OB
Ugeskr Laeger; 2000 Jun; 162(26):3743-7. PubMed ID: 10925639
[TBL] [Abstract][Full Text] [Related]
15. Acid peptic diseases in the era of Helicobacter pylori.
Schoenfeld PS
Lippincotts Prim Care Pract; 1998; 2(4):358-68. PubMed ID: 9709081
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
Mason J; Axon AT; Forman D; Duffett S; Drummond M; Crocombe W; Feltbower R; Mason S; Brown J; Moayyedi P;
Aliment Pharmacol Ther; 2002 Mar; 16(3):559-68. PubMed ID: 11876711
[TBL] [Abstract][Full Text] [Related]
17. Should non-invasive Helicobacter pylori testing replace endoscopy in investigation of dyspepsia?
McColl K
Helicobacter; 2000; 5 Suppl 1():S11-5; discussion S27-31. PubMed ID: 10828749
[TBL] [Abstract][Full Text] [Related]
18. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
Gisbert JP; Hermida C; Pajares JM
Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori and non-malignant upper gastrointestinal diseases.
Vasapolli R; Malfertheiner P; Kandulski A
Helicobacter; 2016 Sep; 21 Suppl 1():30-3. PubMed ID: 27531536
[TBL] [Abstract][Full Text] [Related]
20. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
Kearney DJ; Liu CF; Crump C; Brousal A
Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
